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Liver resection for hepatocellular carcinoma: 
case-matched analysis of laparoscopic versus open 
resection
Ho Hyun Kim, Eun Kyu Park, Jin Shick Seoung, Young Hoe Hur, Yang Seok Koh, Jung Chul Kim, 
Chol Kyoon Cho, Hyun Jong Kim
Division of Hepato-biliary-pancreatic Surgery, Department of Surgery, Chonnam National University Medical School, Gwangju, 
Korea
Purpose: To analyze the outcomes of laparoscopic liver resection compared with open liver resection in patients with hep-
atocellular carcinoma (HCC). Methods:  Between July 2005 and December 2009, 26 consecutive patients with HCC under-
went a pure laparoscopic liver resection, and data from this group (laparoscopic liver resection group, L-group) were com-
pared with a retrospective control group of 29 patients who underwent open liver resection for HCC (open liver resection 
group, O-group) during the same period. The two groups were matched in terms of demographic data, tumor size, degree of 
liver cirrhosis, American Society of Anesthesiology score, type of resection, and tumor location. Results: Median operation 
time and the amount of intraoperative packed red blood cell transfusion in the L-group were 147.5 minutes and 0.35 units, 
respectively. The L-group revealed a shorter operation time (147.5 vs. 220.0 minutes, P = 0.031) than the O-group. No differ-
ence in perioperative morbidity or mortality rates was observed (3.8, 0 vs. 24.1%, 0%; P = 0.054, non-specific, respectively); the 
L-group was associated with a shorter hospital stay than the O-group (11.08 vs. 16.07 days, P = 0.034). After a mean follow-up 
of 23.9 months (range, 0.7 to 59.4 months), the 1-year disease-free survival rate was 84.6% in the L-group and 82.8% in the 
O-group (P = 0.673). Conclusion: Laparoscopic liver resection for HCC is feasible and safe in selected patients and can pro-
duce good surgical results with a shorter postoperative hospital stay and similar outcomes in terms of perioperative morbid-
ity, mortality, and disease-free survival than open resection.
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INTRODUCTION
The indications for laparoscopic liver resection have 
been widening, even for cancer treatment options [1]. 
However, laparoscopic liver resection has various efficacy 
and safety concerns for the procedure, and gas emboli and 
appropriate bleeding control are technical problems [2]. 
Second, port-site implantations and tumor cell seeding 
under a CO2 pneumoperitoneum are of concern to sur-
geons [2]. However, accumulating data have revealed that 
these problems have been overcome [3], and laparoscopic 
liver resection for hepatocellular carcinoma (HCC) seems Laparoscopic versus open liver resection for HCC
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to offer advantages over conventional open surgery in 
terms of shortened postoperative recovery [4-9], immuno-
logical benefits [10], and smaller volumes of ascites [3,5]. 
However, most of these studies have reported typically 
minor hepatic procedures with tumor locations in periph-
eral liver segments (segments 2 to 6), and few were com-
parative [3,4,7,11]. Additionally, the oncological results of 
laparoscopic liver resection for HCC remain a matter of 
debate.
The aim of this study was to analyze the outcomes of 
laparoscopic liver resection compared with open liver re-
section for HCC using a case-matched analysis for tumor 
size, type of resection (including major hepatectomies), 
degree of liver cirrhosis, American Society of Anesthesiol-
ogy (ASA) score, type of resection, and tumor location 
(including segments 7 and 8).
METHODS
Patient population
Between July 2005 and December 2009, 102 patients un-
derwent a liver resection for HCC by a single surgeon, at 
the Chonnam National University Hwasun Hospital, 
Korea. Twenty-nine laparoscopic cases were attempted, 
with three conversions to open hepatectomy (10.3%). The 
remaining 26 cases were completed laparoscopically. In 
contrast, 73 patients (71.5%) had an open procedure. Of 
them, 26 consecutive cases underwent pure laparoscopic 
liver resection (laparoscopic liver resection group, 
L-group) and were compared to a retrospective control 
group of 29 patients who underwent open liver resection 
for HCC (open liver resection group, O-group) by the 
same surgeon during the same period. The data of the 
three cases converted to an open hepatectomy were ex-
cluded because of extreme values, to avoid bias. The pa-
tients in the two groups were matched for gender, age, 
body mass index, tumor size, degree of liver cirrhosis, 
ASA score, type of resection, and tumor location. Three pa-
tients underwent conversion to an open approach (10.3%). 
All procedures were performed according to the same sur-
gical and oncological principles. The patients in the L- and 
O-groups received similar preoperative assessments and 
postoperative management.
Indication for a laparoscopic liver resection
According to the international consensus meeting on 
laparoscopic liver surgery [12], the best indication for a 
laparoscopic liver resection is a patient with solitary le-
sions and tumors sized 5 cm or smaller and located in pe-
ripheral liver segments (segments 2 to 6). Our indications 
for a laparoscopic procedure were tumors 5 cm or less in 
size, no major vascular invasion (e.g., main portal vein or 
main hepatic vein) regardless of the location of the tumor, 
an ASA score ＜4, and disease-free margins. Other in-
dications were the same as for an open liver resection. One 
case with an 8-cm sized mass underwent a laparoscopic 
operation and was included in this study. The tumor was 
located in the periphery and had no major vascular 
invasion. Thus, it was thought that an adequate dis-
ease-free margin could be achieved.
Laparoscopic liver resection surgical procedure 
All operations were performed under general anes-
thesia. A pneumoperitoneum was established using CO2 
gas and then maintained below 10 mmHg to prevent a gas 
embolism. Laparoscopic ultrasonography was routinely 
used to localize tumors and to demonstrate satellite 
nodules. Patient position, trochar placement, and type of 
resection were determined according to tumor location. A 
Harmonic scalpel (Ethicon Endo-Surgery Inc, Cincinnati, 
OH, USA) was primarily applied for the parenchymal 
transection. An anatomically major liver resection was 
usually performed using an intrafascial or extrahepatic 
approach. The portal pedicles were dissected outside the 
liver parenchyma, and the portal branch, the arterial 
branch, and the bile duct were separated. The arterial and 
portal branches were clipped and divided. When the por-
tal branch was too large to apply clips, it was divided with 
a linear stapler. The Pringle maneuver was not performed. 
The resected specimen was inserted into a plastic bag, and 
retrieved through an extended epigastric port site inci-
sion. After meticulous hemostasis, a fibrin glue sealant 
(Greenplast, Green Cross Co., Seoul, Korea) was sprayed 
on the cut surfaces. After irrigation, a closed suction drain 
was inserted, and the wound was closed in layers.Ho Hyun Kim, et al.
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Table 1. Clinicopathological characteristics of patients with 
hepatocellular carcinoma (HCC)
L-group
a) O-group
b) 
P-value
(n = 26) (n = 29)
Age (yr) 57.84 ± 9.66 57.08 ± 9.78 0.773
Gender (male:female) 18:8 20:9 0.983
Body mass index (kg/m
2) 23.81 ± 2.58 22.86 ± 2.46 0.169
Liver cirrhosis 24 (92.3) 25 (86.2) 0.672
Etiology of HCC 0.515
　HBV 16 (61.5) 20 (69.0)
　HCV 2 (7.7) 1 (3.4)
　HBV + HCV 0 (0) 2 (6.9)
　Others   8 (30.8)   6 (20.7)
AFP (log10 ng/mL) 3.25 ± 2.25 4.24 ± 2.83 0.165
ICG-R15 (%) 8.42 ± 7.91 9.14 ± 5.90 0.714
Albumin (mg/mL) 4.41 ± 0.34 4.28 ± 0.44 0.234
Total bilirubin (mg/dL)  0.80 (0.3-2.4) 0.80 (0.3-1.2) 0.939
PT (INR) 1.03 ± 0.063 1.03 ± 0.061 0.891
AST (U/L)   34.0 (17-143) 35.0 (18-159) 0.619
ALT (U/L)   33.5 (11-204) 31.0 (14-143) 0.607
Platelet (×10
3/mL) 149.5 (87-333)  163 (77-784) 0.787
Tumor size (cm) 3.15 (1-8) 3.6 (1-19) 0.394
ASA 0.422
　I   3 (11.5) 2 (6.9)
　II 20 (76.9) 26 (89.7)
　III   3 (11.5) 1 (3.4)
Tumor location 0.392
　Segments 5, 6, 7, 8 18 (69.2) 23 (79.3)
　Segments 2, 3, 4   8 (30.8)   6 (20.7)
Values are presented as mean± SD, median (range), or number (%).
HBV, hepatitis-B virus; HCV, hepatitis-C virus; AFP, alpha 
fetoprotein; ICG-R15, indocyanine green-retention rate at 15 
minutes; PT, prothrombin time; INR, international normalized 
ratio; AST, aspartate aminotransferase; ALT, alanine amino-
transferase; ASA, American Society of Anesthesiologists physical 
status score. 
a)Laparoscopic liver resection-group. 
b)Open liver resection-group.
Outcome measures
The following operative variables were collected for 
each patient: demographics, tumor location and histology, 
size of hepatic lesions, operative details, morbidity, most 
recent follow-up data, disease-free status (e.g., recurrence 
vs. non-recurrence), and date of recurrence. Morbidity 
and postoperative hospital stay were evaluated according 
to the Clavien complication grading system [13,14]. 
Patients were monitored for the development of post-
operative hemorrhage, pleural effusion, and postopera-
tive fluid collection. Patterns of recurrence were classified 
as unifocal intrahepatic, multifocal hepatic, and others 
(e.g., lumbar spine metastasis). Survival status was de-
termined by review of the medical records and through 
use of the Chonnam Regional Cancer Center death index.
Liver resections were defined according to Brisbane 
2000 terminology [15]: left lateral sectionectomy (for a seg-
mentectomy of segments 2 to 3), segmentectomy (for a re-
section of one segment), right hemihepatectomy (for a seg-
mentectomy of segments 5 to 8), and left hemihepatec-
tomy (for a segmentectomy of segments 2 to 4).
Discharge criteria were the ability to tolerate a soft or 
regular hospital diet and pain control with oral analgesics. 
After discharge, all patients were followed with a surveil-
lance protocol that included a multislice computed to-
mography scan, liver function tests, and serum alpha-feto-
protein level every 3 months after resection for 2 years, 
then every 4 to 6 months.
Disease-free survival was calculated from the date of 
the operation to the date of recurrence or last follow-up.
Statistical analyses
Summary statistics are reported using mean or median 
values, where appropriate. The Student’s t-test and Mann- 
Whitney U-test were used for the mean comparison of 
continuous variables and for ordinal data, respectively, 
whereas the chi-squared and Fisher exact tests were used 
to compare frequencies of categorical variables between 
groups. Survival rates were calculated using the Kaplan- 
Meier method, and survival curves were compared using 
the log-rank test. Significance was defined as P ≤  0.05. All 
statistical analyses were performed using the SPSS ver. 
14.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Clinicopathological features and tumor characteristics 
are summarized in Table 1. Additional parameters, such as 
transaminase levels, total bilirubin, and prothrombin 
time, were similar between the L- and O-groups.
Intraoperative clinical outcomes
The intraoperative clinical outcomes are summarized in 
Table 2. In the L-group, there were four right hemi-Laparoscopic versus open liver resection for HCC
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Table 2. Intraoperative clinical outcomes
L-group
a) O-group
b) 
P-value
(n = 26) (n = 29)
Operation procedures 0.462
   Right hemihepatectomy   4 (15.4)   5 (17.2)
   Left hemihepatectomy 1 (3.8) 2 (6.9)
   Segmentectomy   4 (15.4) 10 (34.5)
   LLS   5 (19.2)   3 (10.3)
   Wedge resection 12 (46.2)   9 (31.0)
Conversion to open 3/29 (10.3) -
 resection
Operation time (min) 147.5 (45-500) 220.0 (65-445) 0.031
Intraoperative total amount 0.35 ± 0.75 0.45 ± 0.91 0.666
 of PRC transfusion (unit)
Intraoperative PRC  5 (19.2)   7 (24.1) 0.660
 transfusion
Vascular invasion  5 (19.2)   4 (13.8) 0.721
Satellite nodule  4 (15.4) 2 (6.9) 0.406
Edmondson-Steiner grade 0.926
   Grade I, II    6 (23.1)   7 (24.1)
   Grade III, IV 20 (76.9) 22 (75.9)
Resection margin 1.000
   R0 resection 25 (96.2) 28 (96.6)
   R1 resection 1 (3.8) 1 (3.4)
Values are presented as  number (%) or median (range).
LLS, left lateral sectionectomy; PRC, packed red blood cell.
a)Laparoscopic liver resection group. 
b)Open liver resection group.
Table 3. Postoperative clinical course
L-group
a) O-group
b) 
P-value
(n = 26) (n = 29)
Postoperative mortality 0 (0) 0 (0) NS
Postoperative morbidity    1 (3.8)      7 (24.1) 0.054
   Hemorrhage 0 (0)    2 (6.9)
   Pleural effusion    1 (3.8) 0 (0)
   Abscess 0 (0)    2 (6.9)
   Others (ileus, fluid 0 (0)      3 (10.3)
    collection, etc.)
POD1 bilirubin (mg/dL) 1.4 (0.7-5.3) 1.6 (0.6-3.7) 0.230
POD1 PT (INR) 1.26 ± 0.14 1.38 ± 0.17 0.003
POD1 AST (IU/L) 115.5 (51.0-495.0) 133.0 (63.0-516.0) 0.169
POD1 ALT (IU/L) 114.5 (18.0-294.0) 114.0 (31.0-619.0) 0.853
Postoperative hospital 11.08 ± 4.96 16.07 ± 10.697 0.034
  stay (day)
Values are presented as number (%), median (range), or mean ± SD.
POD, postoperative day; PT, prothrombin time; INR, international
normalized ratio; AST, aspartate aminotransferase; ALT, alanine 
aminotransferase; NS, non- specific.
a)Laparoscopic liver resection group. 
b)Open liver resection group.
hepatectomies, one left hemihepatectomy, four segmen-
tectomies, four left lateral sectionectomies, and 13 wedge 
resections. In the O-group, there were five right hemi-
hepatectomies, two left hemihepatectomies, 10 segmen-
tectomies, three left lateral sectionectomies, and nine 
wedge resections. No difference was found between the 
two groups for the type of resection (P = 0.467). Five pa-
tients (19.2%) in the L-group and seven patients (24.1%) in 
the O-group underwent a major (≥three segments) liver 
resection (P = 0.660), with a 10.3% conversion rate. The me-
dian operation time was shorter in the L-group than that in 
the O-group (147.5 vs. 220.0 minutes, P = 0.031). The total 
amount of intraoperative packed red blood cell trans-
fusion was 0.35 units in the L-group and 0.45 units in the 
O-group (P = 0.666). A transfusion was required in five pa-
tients (19.2%) in the L-group and seven patients (24.1%) in 
the O-group (P = 0.660). In both groups, one case had tu-
mor exposure at the surgical specimen surface (R1 re-
section; P = 1.000). The two groups did not differ sig-
nificantly in terms of the presence of vascular invasion, 
satellite nodules, or Edmondson-Steiner grade.
The size of the skin incision in the L-group was 6 to 7 cm 
for the major (≥3 segments) liver resection hepatectomies 
and ＜5 cm for the minor (＜3 segments) resections, which 
was shorter than that in the O-group (about 10 to 15 cm).
Postoperative clinical outcomes
We compared the postoperative clinical outcomes be-
tween the two groups (Table 3). No perioperative death 
was recorded in either group. Postoperative complications 
occurred in one patient in the L-group (3.8%) and in seven 
patients in the O-group (24.1%; P = 0.054). Based on the 
surgical complications classification [13,14], complica-
tions in the L-group included grade II pleural effusion, 
which resolved successfully with diuretic treatment. In 
the O-group, postoperative complications included one 
case of grade II hemorrhage, one case of grade III hemor-
rhage (treated with a re-exploration for bleeding from a re-
section margin), two cases of grade II abscess, and one case 
each of ileus (grade II), ascites (grade II), and fluid collec-
tion (grade I).
The peak postoperative values of total bilirubin, aspar-
tate aminotransferase, and alanine aminotransferase did 
not differ statistically between the two groups. However, Ho Hyun Kim, et al.
416 thesurgery.or.kr
Table 4. Follow-up
L-group
a) O-group
b) 
P-value
(n = 26) (n = 29)
Death 0 (0)   3 (10.3) NS
Disease recurrence 7 (26.9)  10 (34.5) 0.545
   Unifocal intrahepatic 5 (71.4) 5 (50)
   Multifocal hepatic 2 (28.6) 4 (40)
   Other (lumbar spine) 0 (0) 1 (10)
Disease free survival (mo) 13.4 (0.2-58.3) 14.6 (1.4-59.1) 0.673
Therapy of recurrence 0.769
   Re-operation 2 (28.6) 1 (10.0)
   TACE 2 (28.6) 4 (40.0)
   RFA 2 (28.6) 2 (20.0)
   Others 1 (14.3) 3 (30.0)
Values are presented as number (%) or median (range).
TACE, transarterial chemoembolization; RFA, radiofrequency 
ablation; NS, non-specific.
a)Laparoscopic liver resection group; 
b)Open liver resection group.
Fig. 1. Disease-free survival curves after laparoscopic and open 
liver resection for hepatocellular carcinoma (P = 0.073).
the prothrombin time value at postoperative day 1 in the 
L-group was lower than that in the O-group (1.26 vs. 1.38 
international normalized ratio, P = 0.003).
The mean hospital stay after surgery was significantly 
shorter in the L-group than in the O-group (11.08 vs. 16.07 
days; P = 0.034).
Follow-up and disease-free survival
Follow-up and survival are summarized in Table 4. The 
mean follow-up period was 21.75 months (range, 0.7 to 
58.4 months) for the L-group and 24.75 months (range, 3.6 
to 59.4 months) for the O-group. Seven of the 26 patients in 
the L-group developed disease recurrence (unifocal intra-
hepatic recurrence, n = 5; multifocal hepatic recurrence, n 
= 2). No patient developed tumor recurrence at the site of 
the resection margin, peritoneal dissemination, or port- 
site metastases. Ten of the 29 patients in the O-group de-
veloped tumor recurrence (unifocal intrahepatic recur-
rence, n = 5; multifocal hepatic recurrence, n = 4; lum-
bar-spine metastasis, n = 1). The 1-year disease-free surviv-
al rate was 84.6% for the L-group and 82.8% for the 
O-group (P = 1.000) (Fig. 1).
In the L-group, recurrence were treated by further sur-
gery (2 patients), transarterial chemoembolization (trans-
arterial chemoembolization [TACE]; 2), radio-frequency 
ablation (radiofrequency ablation [RFA]; 2), and refusal of 
any form of therapy [1], while patients with a recurrence 
were treated by re-resection [1], TACE [4], RFA [2], radio-
therapy [1], and refusal of any form of therapy [2] in the 
O-group.
No patients died in the L-group, whereas three patients 
died in the O-group, and median overall survival was 25.6 
months (range, 3.6 to 59.4 months).
DISCUSSION
Since the first report of laparoscopic liver resection by 
Gagner et al. [16] in 1992, an increasing number of small 
prospective studies have been published. These studies 
have reported encouraging results for the feasibility and 
safety of the procedure. Laparoscopic resection has been 
more frequently proposed as a curative treatment for HCC 
[3,6-8,11,17-19] or as a preliminary treatment before trans-
plantation [20].
However, laparoscopic liver resection for HCC is still 
challenging for both surgeons and patients, because most 
HCCs are associated with underlying liver disease, such 
as chronic hepatitis and liver cirrhosis. Moreover, apply-
ing laparoscopic resection to HCC has been limited by tu-
mor location. Most reported cases had peripheral lesions 
located in the anterolateral segments (segments 2, 3, 4b, 5, 
and 6) [3,7,17-19,21]. Additionally, major liver resections 
(i.e., right or left hemihepatectomies) are feasible, but re-
main difficult procedures that should be reserved for ex-
perienced surgeons [12]. In our study, tumor location in Laparoscopic versus open liver resection for HCC
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Table 5. Published series of matched comparative studies of laparoscopic and open hepatic resection for hepatocellular carcinoma
Author Year
No. of cases 
(L:O)
Operating time 
(L:O, min)
(P-value)
Transfusion 
(L:O, n (%))
(P-value)
Postoperative 
hospital stay
(L:O, day)
(P-value)
Postoperative 
complications
 (L:O, n (%))
(P-value)
Mortality 
(L:O, n (%))
(P-value)
DFS rate 
(P-value)
Aldrighetti et al. [4] 2010 16:16 150:240  4:6 (25:37.5) 6.3:9  4:7 (25:43.7)  0:0  NS
(0.044) (NS) (0.039) (NS) (NS)
Tranchart et al. [5] 2010 42:42 233.1:221.8 4:7 (9.5:16.7) 6.7:9.6  5:12 (11.9:28.5)  1:1 (2.4:2.4)  -
(0.90) (0.51) (＜0.0001) (0.10) (1.00)
Belli et al. [22] 2009 54:125 167:185  6:31 (11:25.6) 8.4:9.2  10:45 (19:36) 1:5 (2:4) 0.864
(0.012) (0.030) (0.113) (0.020) (0.615)
Belli et al. [6] 2007 23:23 148:125.2  0:4 (0:17.3) 8.2:12.04  3:11 (13:47.8) 1:0 (4.3:0)  -
(0.016) (0.036) (0.048) (0.01) (NS)
Kaneko et. al. [7] 2005 30:28 182:210  - 14.9:21.6 3:5 (10:18)  0 : 0  NS
(NS) (＜0.005) (NS) (NS)
Laurent et al. [3] 2003 13:14 267:182  1:4 (7.7:28.6) 15.3:17.3 4:7 (36:50)  0:2 (0:14) NS
(0.006) (0.490) (0.830) (NS) (0.2)
Shimada et al. [8] 2001 17:38 325:280  1:4 (5.9:10.5) 12:22 1:4 (5.9:10.5) - NS
(0.18) (0.990) (＜0.001) (0.99)
Present study 2011 26:29 147.5:220.0 5:7 (19.2:24.1) 11.1:16.1 1:7 (3.8:24.1)  0:0  0.673
(0.031) (0.660) (0.034) (0.054) (NS)
L, Laparoscopic resection; O, Open resection; DFS, disease-free survival, NS, non-specific.
laparoscopic liver resections included three cases (11.5%) 
in segment 7 and two cases (7.7%) in segment 8. Five pa-
tients (19.2%) in the L-group underwent major (≥3 seg-
ments) liver resection. This result suggests that the limi-
tations of laparoscopic resection based on tumor location 
and the extent of resection will be overcome with further 
experience and technical advances.
One of the advantages of laparoscopic liver resection is 
a shorter operation time than for the open method. 
Aldrighetti et al. [4] reported that the laparoscopic ap-
proach resulted in a shorter operating time (150 vs. 240 mi-
nutes, P = 0.044) in a case-matched analysis of laparoscopic 
(n = 16) and open liver resection (n = 16) of HCC. 
Additionally, Belli et al. [22] reported a retrospective anal-
ysis of a prospectively maintained database of 179 liver re-
sections including major hepatectomies. They showed a 
shorter operating time with laparoscopic versus open liver 
resection (167 vs. 185 minutes, P = 0.012). These results are 
comparable with the results of the present study.
Sarpel et al. [9] matched 20 laparoscopic liver resections 
for HCC to 56 open resections for HCC. The adjusted odds 
ratio for a length of stay ≥6 days was significantly lower in 
patients who underwent a laparoscopic resection. These 
results are comparable with the results of the present 
study showing a shorter postoperative hospital stay for 
patients who underwent a laparoscopic resection (11.1 vs. 
16.1 days, P = 0.034).
The main concern with using the laparoscopic techni-
que for malignancies is the risk of inadequate tumor 
resection. However, no difference has been observed in 
margin-free resections between laparoscopic and open liv-
er resection in many comparative studies [3,5-6,9,12, 
23-26]. In our series, one case in each group had tumor ex-
posure at the surgical specimen surface (R1 resection); this 
was not significant (P = 1.000).
Another concern about laparoscopic resection of malig-
nancies is the risk for a port-site tumor recurrence, which 
was not recorded in our patients. With more than 3,000 
cases of minimally invasive hepatic resection in the liter-
ature, no incidence of port-site recurrence or tumor seed-
ing has been reported [3-8,22]. Thus, this concern should 
not prevent surgeons from conducting a laparoscopic 
approach.
Both groups underwent surgery performed by the same 
surgeon, confirming the feasibility and safety of the lapa-
roscopic approach when performed by a surgeon with ex-
perience in both open and laparoscopic liver surgery. In 
fact, the mortality and the morbidity rates for the laparo-Ho Hyun Kim, et al.
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scopic resection group were 0% and 3.8%, respectively.
No prospective, randomized controlled trial has been 
reported comparing laparoscopic with open liver resec-
tion. However, several studies have provided outcomes of 
matched comparisons between laparoscopic and open 
hepatic resection for HCC (Table 5). Belli et al. [22] pro-
vided the largest matched comparison of laparoscopy (n = 
54) with open liver resection (n = 125) of HCC in patients 
with cirrhosis. Mortalities at 30 days were similar between 
the two groups; however, morbidity was significantly 
lower in the laparoscopic group (19 vs. 36%, P = 0.020). The 
3-year overall survival (67 vs. 62%, P = 0.347) and disease- 
free survival (52 vs. 59%, P = 0.864) were not significantly 
different between the laparoscopic and open groups. 
These results are comparable with the results of other 
studies showing an overall 3-year survival of 60 to 93%, 
and 3-year disease-free survival of 52 to 64% after laparo-
scopic liver resection for HCC [11,18,19]. In our study, 
three patients died in the O-group, and the 2-year overall 
survival rate was 93.1%. No patients died in the L-group 
during the follow-up period. Thus, overall survival in the 
L-group could not be calculated and compared with that 
of the O-group. Nevertheless, our study confirmed the fea-
sibility, safety, and benefits of laparoscopic liver resection 
for selected patients, including HCCs located in segments 
7 and 8 and major hepatectomies.
The results of our study are limited by the non-random-
ized design, small number of cases, and the selection bias 
related to the choice of approach based merely on tumor 
characteristics. Although the potential historical bias was 
reduced by the study design, resulting in an open re-
section group that was well matched with a laparoscopic 
resection group for age, gender, ASA class, tumor location 
and size, type of liver resection, and degree of liver cir-
rhosis, our disease-free survival results after laparoscopic 
liver resection for HCC are short-term results. Thus, a larg-
er group of patients and further examinations (longer- 
term follow-up) are necessary to analyze the role of lapa-
roscopic liver resection.
In conclusion, the present study showed that laparo-
scopic liver resection for HCC is feasible and safe in se-
lected patients and can lead to good surgical results with a 
shorter postoperative hospital stay, shorter operating 
time, less intraoperative bleeding, and similar outcomes in 
terms of disease-free survival when compared with open 
surgery.
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